Key Takeaways
The new HORIBA East Coast Analytical Solution Plaza (ASP) in Piscataway, New Jersey, bridges the gap between advanced scientific instrumentation and real-world industrial application. By providing a modular, 15,000-square-foot laboratory environment, this facility empowers researchers in biopharma, life sciences, and materials to solve complex analytical challenges collaboratively. Whether validating a new protocol or evaluating orthogonal measurement methods prior to procurement, the ASP offers a flexible, fully equipped space tailored to accelerate research and development workflows.
Source: GEN - Genetic Engineering & Biotechnology News, "HORIBA Expands Customer-Focused Solutions with New East Coast Analytical Solution Plaza" (October 5, 2026). Read it here.
Overcoming the barrier of tight budgets and rising laboratory equipment costs, the Analytical Solution Plaza (ASP) allows customers to evaluate advanced analytical technologies and optimize methodologies before purchase. This collaborative facility provides direct access to Fluorescence and Raman Spectroscopy instruments to solve your most demanding material characterization pain points.
Beyond validating initial instrument capabilities, the center emphasizes shifting from transactional sales to problem-solving partnerships. HORIBA application scientists work directly with your samples to determine whether techniques like Particle Characterization or custom-developed solutions best meet your evolving project requirements.
To resolve bottlenecks in highly sensitive therapeutic characterization, the Piscataway facility is equipped with a comprehensive suite of instruments including the Veloci Biopharma Analyzer, LabRAM Odyssey, and LabRAM Soleil. Researchers can evaluate samples in real-time, rapidly pivoting between orthogonal measurement methods to identify the optimal technology for their specific use case.
Following the establishment of accurate baseline metrics, our experts help configure these modular, wheel-mounted systems to fit your specific workflow. This flexibility ensures that whether you are differentiating AAV subtypes or analyzing antibody-drug conjugates, you have the right tools available.
Addressing the urgent need to overcome the limits of detection found in historical technologies like near-IR, the new East Coast plaza provides organizations with immediate access to novel biotherapeutic characterization tools. By leveraging collaborative methodology development, local pharmaceutical sectors can significantly accelerate feasibility testing from simplified models to real process samples.
Once your core analytical protocols are finalized, the facility's location in the tri-state biopharma corridor ensures continued, face-to-face scientific support. This approach empowers R&D teams to navigate changing market requirements without absorbing the high upfront costs of unproven equipment.
如您有任何疑問，请在此留下詳細需求或問題，我們將竭誠您服務。
